JAMA editorial highlights pros, cons of D2C telemedicine services
Direct-to-consumer telemedicine services have attracted plenty of attention from investors and patients alike, due in part to their lower costs and ease of use. From a medical standpoint, however,...
View ArticleRo cofounder calls out competitor Hims for similarities in platform
There are some striking similarities between mail-order sexual health companies Ro and Hims: Both started out focused on men’s sexual health, both employ telemedicine and if you ride the subway in a...
View ArticleRo launches WebMD-like health information website
Direct-to-consumer virtual health company Ro launched a new health information platform dubbed Health Guide. Currently the platform covers sexual health, hair loss, weight management, diabetes, and...
View ArticleVirtual care company Ro launches prescription allergy service
Direct-to-consumer virtual health company Ro is now offering allergy care. The launch means that users of Roman and Rory will be able to get prescription allergy medications through the platform’s...
View ArticleRo dips into skincare with new prescription dermatology line
Ro, a direct-to-consumer virtual health startup best known for its sexual health products, is dipping into the dermatology space. Patients will now be able to use the service for prescription products...
View ArticleRo receives $200 million in funding and is now valued at $1.5 billion
Direct-to-consumer virtual health company Ro announced Monday it’s $200 million Series C funding round. With these additional funds, the company is now valued at $1.5 billion.The existing investor,...
View ArticleRo expands reach to in-home healthcare with purchase of Workpath
Direct-to-consumer virtual health company Ro is turning to the in-home healthcare space with the acquisition of digital platform Workpath. Founded in 2015, Workpath created a tool that can offer...
View ArticleRo raises $500M, bringing its D2C virtual care business to a $5B valuation
Direct-to-consumer virtual care and mail-order prescription startup Ro is adding to its already impressive fundraising haul with a fresh $500 million investment headed by prior backers General...
View ArticlePatients can now get anxiety and depression medications via Ro's...
Direct-to-consumer virtual care company Ro is rolling out a new mental health platform, dubbed Ro Mind, that will initially focus on generalized anxiety disorder (GAD) and major depressive disorder...
View ArticleRo CEO shoots back after report on employee dissatisfaction
Employee morale is low and turnover is high at direct-to-consumer virtual care company Ro, as the company struggles to expand its success beyond erectile dysfunction medication, according to reporting...
View Article
